Ovarian reserve in young juvenile idiopathic arthritis patients

References

• Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377:2138–49.
   PubMed Web of Science ®Google Scholar
• Pugliese C, van der Vinne RT, Campos LM, Guardieiro PR, Saviolli C, Bonfa E. Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease? Clin Rheumatol. 2016;35:81–91.
   PubMed Web of Science ®Google Scholar
• Gualano B, Bonfa E, Pereira RM, Silva CA. Physical activity for paediatric rheumatic diseases: standing up against old paradigms. Nat Rev Rheumatol. 2017;13:368–79.
   PubMed Web of Science ®Google Scholar
• Silva CA, Brunner HI. Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus. 2007;16:593–9.
   PubMed Web of Science ®Google Scholar
• Silva CA, Bonfa E, Østensen M. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res. 2010;62:1682–90.
   PubMed Web of Science ®Google Scholar
• Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A, et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford). 2011;50:657–64.
   PubMed Web of Science ®Google Scholar
• Silva CA, Yamakami LY, Aikawa NE, Araujo DB, Carvalho JF, Bonfá E. Autoimmune primary ovarian insufficiency. Autoimmun Rev. 2014;13:427–30.
   PubMed Web of Science ®Google Scholar
• de Araujo DB, Yamakami LY, Aikawa NE, Bonfá E, Viana VS, Pasoto SG, et al. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol. 2014;43:503–11.
   PubMed Web of Science ®Google Scholar
• Aikawa NE, Sallum AM, Leal MM, Bonfá E, Pereira RM, Silva CA. Menstrual and hormonal alterations in juvenile dermatomyositis. Clin Exp Rheumatol. 2010;28:571–5.
   PubMed Web of Science ®Google Scholar
• Aikawa NE, Sallum AM, Pereira RM, Suzuki L, Viana VS, Bonfa E, et al. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol. 2012;30:445–9.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.
   PubMed Web of Science ®Google Scholar
• Almeida PM, Wickerrhauser H. Critério de classe econômica da Associação Brasileira de Anunciantes (ABA) e Associação Brasileira dos Institutos de Pesquisa de Mercado (ABIPEME); 1991. p. 1–29.
   Google Scholar
• Silva CA, Leal MM, Leone C, Simone VP, Takiuti AD, Saito MI, et al. Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus. 2002;11:419–25.
   PubMed Web of Science ®Google Scholar
• Medeiros PB, Febronio MV, Bonfa E, Borba EF, Takiuti AD, Silva CA. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus. 2009;18:38–43.
   PubMed Web of Science ®Google Scholar
• Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291–301.
   PubMed Web of Science ®Google Scholar
• Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril. 2007;87:764–75.
   PubMed Web of Science ®Google Scholar
• Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder – a plea for universal definitions. J Assist Reprod Genet. 2015;32:1709–12.
   PubMed Web of Science ®Google Scholar
• Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol. 1999;26:1087–93.
   PubMed Web of Science ®Google Scholar
• Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Paediatric Rheumatology International Trials Organisation, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658–66.
   PubMed Web of Science ®Google Scholar
• van Riel PLCM. The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). Clin Exp Rheumatol. 2014;32:65–74.
   Web of Science ®Google Scholar
• Machado CS, Ruperto N, Silva CH, Ferriani VP, Roscoe I, Campos LM, et al. Paediatric Rheumatology International Trials Organisation. The Brazilian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. 2001;19:25–9.
   Google Scholar
• Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P. Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol. 1990;17:813–7.
   PubMed Web of Science ®Google Scholar
• Klatchoian DA, Len CA, Terreri MT, Silva M, Itamoto C, Ciconelli RM, et al. Quality of life of children and adolescents from São Paulo: reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory version 4.0 Generic Core Scales. J Pediatr (Rio J). 2008;84:308–15.
   PubMed Web of Science ®Google Scholar
• Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rer Bras Rheumatol. 1999;39:3.
   Google Scholar
• Yamakami LY, de Araujo DB, Silva CA, Baracat EC, de Carvalho JF. Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome. Lupus. 2011;20:523–6.
   PubMed Web of Science ®Google Scholar
• Mont'Alverne AR, Pereira RM, Yamakami LY, Viana VS, Baracat EC, Bonfá E, et al. Reduced ovarian reserve in patients with Takayasu arteritis. J Rheumatol. 2014;41:2055–9.
   PubMed Web of Science ®Google Scholar
• Mont'Alverne AR, Yamakami LY, Gonçalves CR, Baracat EC, Bonfá E, Silva CA. Diminished ovarian reserve in Behçet's disease patients. Clin Rheumatol. 2015;34:179–83.
   PubMed Web of Science ®Google Scholar
• Yamakami LY, Serafini PC, de Araujo DB, Bonfá E, Leon EP, Baracat EC, et al. Ovarian reserve in women with primary antiphospholipid syndrome. Lupus. 2014;23:862–7.
   PubMed Web of Science ®Google Scholar
• Yamakami LY, Serafini PC, de Araujo DB, Bonfá E, Leon EP, Baracat EC, et al. Ovarian reserve in antiphospholipid syndrome: the jury is still out. Lupus. 2015;24:773; Lupus. 2015;24:1007.
   PubMed Web of Science ®Google Scholar
• de Souza FH, Shinjo SK, Yamakami LY, Viana VS, Baracat EC, Bonfá E, et al. Reduction of ovarian reserve in adult patients with dermatomyositis. Clin Exp Rheumatol. 2015;33:44–9.
   PubMed Web of Science ®Google Scholar
• de Souza FH, da Silva CA, Yamakami LY, dos Santos Trindade Viana V, Bonfá E, Shinjo SK. Reduced ovarian reserve in patients with adult polymyositis. Clin Rheumatol. 2015;34:1795–9.
   PubMed Web of Science ®Google Scholar
• Kristensen SL, Ramlau-Hansen CH, Andersen CY, Ernst E, Olsen SF, Bonde JP, et al. The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women. Fertil Steril. 2012;97:779–85.
   PubMed Web of Science ®Google Scholar
• Testing and interpreting measures of ovarian reserve: a committee opinion. Practice Committee of the American Society for Reproductive Medicine. Fertil Steril. 2015;103:e9–e17.
   PubMed Web of Science ®Google Scholar
• David J, Vouyiouka O, Ansell BM, Hall A, Woo P. Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol. 1993;11:85–90.
   PubMed Web of Science ®Google Scholar
• Packham JC, Hall MA. Premature ovarian failure in women with juvenile idiopathic arthritis (JIA). Clin Exp Rheumatol. 2003;21:347–50.
   PubMed Web of Science ®Google Scholar
• Brouwer J, Laven JS, Hazes JM, Schipper I, Dolhain RJ. Levels of serum anti-Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65:1534–8.
   PubMed Web of Science ®Google Scholar
• Henes M, Froeschlin J, Taran FA, Brucker S, Rall KK, Xenitidis T, et al. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet's disease and spondyloarthritis on anti-Müllerian hormone levels. Rheumatology (Oxford). 2015;54:1709–12.
   PubMed Web of Science ®Google Scholar
• Karakus S, Sahin A, Durmaz Y, Aydin H, Yildiz C, Akkar O, et al. Evaluation of ovarian reserve using anti-Müllerian hormone and antral follicle count in Sjögren's syndrome: preliminary study. J Obstet Gynaecol Res. 2017;43:303–7.
   PubMed Web of Science ®Google Scholar
• Febronio MV, Pereira RM, Bonfa E, Takiuti AD, Pereyra EA, Silva CA. Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus. Lupus. 2007;16:430–5.
   PubMed Web of Science ®Google Scholar